Opinion

By Pharm. Melody Okereke

NIGERIA’S HIV response has travelled a long road. A diagnosis that once carried fear and uncertainty is now a condition that can be managed with effective treatment. Today, a person living with HIV can take antiretroviral medicines, achieve viral suppression, build a family, pursue a career, and live a healthy life. This progress did not happen by chance. It came from years of research, advocacy, policy decisions, community action, and the commitment of healthcare workers who have supported people through their HIV journey.

Yet, an important question remains. If we already know what works, why are some people still being left behind?

Nigeria does not lack HIV knowledge. We know that early diagnosis saves lives. We know that antiretroviral therapy prevents illness and reduces HIV transmission. We know that prevention services and community-based approaches can improve outcomes. The challenge is making sure these solutions reach the people who need them, when they need them, and in ways that fit the realities of their daily lives. This is where implementation science becomes important.

Implementation science is about understanding what happens after research has shown that something works. It looks at how health interventions move from guidelines, studies, and conference presentations into real communities and healthcare settings. It asks why a programme that succeeds in one location may struggle somewhere else and what changes are needed to make healthcare work better for different populations. In HIV care, this difference matters.

A person may receive an HIV diagnosis today and be told that treatment is available. But between that moment and achieving viral suppression, there are many things that can happen. The person may worry about what their family will think. They may fear being recognised at the clinic. They may struggle with transportation costs or the need to take time away from work. They may experience emotional distress after learning their status.

The medicine may be available, but the journey to that medicine is influenced by many factors.

Through experiences in HIV programmes and implementation research, I have seen that healthcare decisions are rarely based on medical information alone. People make decisions within the realities of their families, communities, finances, and personal experiences. A patient does not walk into a clinic carrying only a health condition. They come with fears, responsibilities, questions, and concerns that also need attention. This is why having medicines and guidelines is not enough.

For many years, the HIV response has focused on important achievements such as increasing testing, expanding treatment access, and improving viral suppression rates. These achievements matter. They show how far we have come. However, numbers alone cannot always explain why some people remain outside care. Behind every missed appointment is a person. Behind every late diagnosis is a story. Behind every person who stops treatment is a reason that health systems need to understand.

A patient may stop attending clinic visits because transportation has become too expensive. Another may avoid collecting medicines because they are afraid someone will see them at the HIV clinic. A young person may avoid testing because they are worried about confidentiality. These situations are not simply individual choices. They reflect how well our health systems understand the people they are designed to serve.

Implementation science helps us pay attention to these realities.

A treatment can work perfectly in a clinical trial, but delivering that treatment in everyday life presents different challenges. Healthcare workers may need additional support. Communities may need better engagement. Services may need to be redesigned to protect privacy and reduce barriers. Programmes may need to move closer to where people live rather than expecting everyone to navigate complicated healthcare systems.

Nigeria’s diversity makes this even more important. The barriers facing a young person seeking HIV services in Lagos may not be the same as those affecting someone living in a rural community or a hard-to-reach riverine area. An approach that works in one setting may need to be adapted before it can succeed somewhere else. The people closest to these challenges often understand the solutions best.

Community health workers, peer educators, pharmacists, healthcare providers, and local organisations often serve as the connection between health systems and communities. They hear the questions people are afraid to ask. They understand why someone may delay seeking care. They know the practical barriers that may never appear in a report or spreadsheet.

Sometimes, what brings a person back to care is not a new policy document or another awareness campaign. Sometimes, it is a healthcare worker who listens without judgement. Sometimes, it is a community member who creates a safe space. Sometimes, it is a service designed around the realities of people’s lives. Trust is not separate from healthcare. Trust is part of healthcare.

As Nigeria continues its HIV response, we must move beyond asking whether we have effective interventions. We must ask whether those interventions are reaching the people who need them most. Who are we still missing? Why are they being missed? What can we change to make care easier, safer, and more acceptable? These are the questions implementation science helps answer.

The next phase of Nigeria’s HIV response will not only depend on discovering new tools. It will depend on improving how existing tools are delivered. It will require listening to communities, strengthening health systems, using data to guide decisions, and designing programmes that reflect real human experiences.

The evidence already exists. The medicines already exist. The knowledge already exists. The challenge now is making sure that every person who needs these solutions can truly benefit from them. Because the success of Nigeria’s HIV response will not only be measured by the number of people who receive treatment. It will be measured by the number of people who are reached, supported, and able to live healthy lives because the system worked for them.

***Pharm. Melody Okereke is a pharmacist and HIV/AIDS implementation science researcher, working on health systems innovation, harm reduction, and community-driven approaches to improving healthcare access and outcomes.

A.I

Aug. 20, 2026

Tags: Pharm. Melody Okereke

Post navigation